Michael Kleinemeier Chairman of the Merck Supervisory Board until the 2024 AGM
Michael Kleinemeier will serve as Chair of the Supervisory Board until April 26, 2024, when the Merck Annual General Meeting is scheduled to elect six new shareholder representatives to the Supervisory Board. The Supervisory Board position made vacant by the departure of Wolfgang Büchele will then be newly filled and another Supervisory Board member will be elected. Until then, the Supervisory Board will temporarily operate with 15 members instead of the usual 16. After the 2024 Annual General Meeting, the new Supervisory Board will elect a chairperson.
Michael Kleinemeier will continue to serve as a Member of the Board of Partners of E. Merck KG.
Most read news
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.